+44 330 822 4832
+44 330 822 4832
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Epidemiology: 黑料网 have been cited by esteemed scholars and scientists all around the world. Epidemiology: 黑料网 has got h-index 22, which means every article in Epidemiology: 黑料网 has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: 黑料网.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
| Journal total citations count | 3849 |
| Journal impact factor | 10.58 |
| Journal 5 years impact factor | 10.09 |
| Journal cite score | 10.22 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 18 |
 |
Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union |
| | | | |
|
Quit Smoke or Quit Your Life With Stroke! |
| | | | |
|
Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation |
| | | | |
|
Prevalence and predictors of midwakh smoking among male students of Qassim University, Al-Qassim, Saudi Arabia |
| | | | |
|
An Evaluation of the Effectiveness of Risk Minimization Measures for Tigecycline in the European Union |
| | | | |
|
Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999芒聙聯2012 |
| | | | |
|
Cancer Incidence in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998芒聙聯2009 |
| | | | |
|
Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries |
| | | | |
|
Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology |
| | | | |
|
Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective |
| | | | |
|
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review |
| | | | |
|
The effectiveness of direct to healthcare professional communication 芒聙聯 A systematic review of communication factor studies |
| | | | |
|
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study |
| | | | |
|
Study design, process and outcome indicators of post-authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register |
| | | | |
|
Recent Developments in EU and US Pharmacovigilance Legislation |
| | | | |
|
A comparison of pregnancy prevention programmes in Europe |
| | | | |
|
Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy |
| | | | |
|
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 脗碌g: A Cross-Sectional Physician Survey |
| | | | |
|
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands |
| | | | |
|
A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015 |
| | | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals
